Home Cart Sign in  
Chemical Structure| 34368-52-0 Chemical Structure| 34368-52-0
Chemical Structure| 34368-52-0

(S)-3-Hydroxypyrrolidin-2-one

CAS No.: 34368-52-0

4.5 *For Research Use Only !

Cat. No.: A160308 Purity: 97%

Change View

Size Price

US Stock

Global Stock

In Stock
1g łÇͶÊÊ Inquiry Inquiry
5g łË§¶ÊÊ Inquiry Inquiry
10g łËó¶ÊÊ Inquiry Inquiry
25g łÿî¶ÊÊ Inquiry Inquiry
100g łËÇÿ¶ÊÊ Inquiry Inquiry
500g łÇÊďǶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1g

    łÇͶÊÊ

  • 5g

    łË§¶ÊÊ

  • 10g

    łËó¶ÊÊ

  • 25g

    łÿî¶ÊÊ

  • 100g

    łËÇÿ¶ÊÊ

  • 500g

    łÇÊďǶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 34368-52-0 ]

CAS No. :34368-52-0
Formula : C4H7NO2
M.W : 101.10
SMILES Code : O=C1NCC[C@@H]1O
MDL No. :MFCD06796625

Safety of [ 34368-52-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 34368-52-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 7
Num. arom. heavy atoms 0
Fraction Csp3 0.75
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 27.31
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

49.33 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.82
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.95
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-1.51
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-1.19
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.16
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.54

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

0.13
Solubility 137.0 mg/ml ; 1.35 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

0.4
Solubility 253.0 mg/ml ; 2.5 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.05
Solubility 90.7 mg/ml ; 0.897 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.59 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.41

Application In Synthesis of [ 34368-52-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 34368-52-0 ]
  • Downstream synthetic route of [ 34368-52-0 ]

[ 34368-52-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 3938-83-8 ]
  • [ 34368-52-0 ]
YieldReaction ConditionsOperation in experiment
12.9% With aluminum oxide In toluene for 19 h; Reflux; Dean-Stark Compound 27: Compound 1 (l .Og, 8.40 mmol ) and alumina (2.57g, 25.20 mmol) were suspended in toluene (43 mL) and heated to reflux with attached Dean- Stark apparatus. The reaction was allowed to proceed at reflux for 19 hours. The reaction was filtered and the solid washed with CH2CI2. The filtrate was then collected and concentrated to yield compound 27 as colorless crystals (0.1 10 g, 12.9percent). Using FI RM S analysis, the composition of compound 27 was determined to be CiH NChNa. Measured mass was 124.0371 ; theoretical mass was 124.0369. NMR analysis results for compound 27 were NMR (600 MHz, CDC I3) δ 7.63 (bs, I H), 5.35 (d, J 5.4 Hz, 1H), 4.02-3.95 (m, I H), 3.18-3.12 (m, 1H), 3. 1 I - 3.04 (m, I H), 2.28-2.21 (m, IH), 1.79- 1.69 (m, I H). 13C NMR (151 MHz, CDCI3) δ 176.7, 68.4, 37.5, 30.5.
References: [1] Synlett, 2008, # 13, p. 2028 - 2032.
[2] Journal of the American Chemical Society, 2000, vol. 122, # 2, p. 408 - 409.
[3] Patent: WO2016/164828, 2016, A1, . Location in patent: Page/Page column 26.
[4] Bulletin de la Societe Chimique de France, 1987, # 2, p. 297 - 301.
[5] Journal of the Chemical Society, Chemical Communications, 1995, # 2, p. 231 - 232.
[6] Patent: WO2011/13141, 2011, A2, . Location in patent: Page/Page column 50; 51.
[7] Patent: US2012/184544, 2012, A1, . Location in patent: Page/Page column 24.
[8] Patent: WO2014/8285, 2014, A1, . Location in patent: Page/Page column 165.
[9] Journal of Organic Chemistry, 2018, vol. 83, # 13, p. 7085 - 7101.
  • 2
  • [ 630127-11-6 ]
  • [ 34368-52-0 ]
References: [1] Heterocycles, 2003, vol. 60, # 8, p. 1833 - 1841.
  • 3
  • [ 194034-36-1 ]
  • [ 34368-52-0 ]
References: [1] Tetrahedron, 1997, vol. 53, # 27, p. 9213 - 9218.
  • 4
  • [ 194034-43-0 ]
  • [ 34368-52-0 ]
References: [1] Tetrahedron, 1997, vol. 53, # 27, p. 9213 - 9218.
  • 5
  • [ 111466-53-6 ]
  • [ 34368-52-0 ]
References: [1] Bulletin de la Societe Chimique de France, 1987, # 2, p. 297 - 301.
 

Historical Records

Categories

Related Functional Groups of
[ 34368-52-0 ]

Alcohols

Chemical Structure| 77510-50-0

A155432 [77510-50-0]

(R)-3-Hydroxypyrrolidin-2-one

Similarity: 1.00

Chemical Structure| 15166-68-4

A158781 [15166-68-4]

3-Hydroxy-2-pyrrolidinone

Similarity: 1.00

Chemical Structure| 25747-41-5

A106534 [25747-41-5]

4-Hydroxy-2-pyrrolidone

Similarity: 0.89

Chemical Structure| 68108-18-9

A181193 [68108-18-9]

(S)-4-Hydroxypyrrolidine-2-one

Similarity: 0.89

Chemical Structure| 22677-21-0

A369559 [22677-21-0]

(R)-4-Hydroxypyrrolidin-2-one

Similarity: 0.89

Amides

Chemical Structure| 77510-50-0

A155432 [77510-50-0]

(R)-3-Hydroxypyrrolidin-2-one

Similarity: 1.00

Chemical Structure| 15166-68-4

A158781 [15166-68-4]

3-Hydroxy-2-pyrrolidinone

Similarity: 1.00

Chemical Structure| 25747-41-5

A106534 [25747-41-5]

4-Hydroxy-2-pyrrolidone

Similarity: 0.89

Chemical Structure| 68108-18-9

A181193 [68108-18-9]

(S)-4-Hydroxypyrrolidine-2-one

Similarity: 0.89

Chemical Structure| 22677-21-0

A369559 [22677-21-0]

(R)-4-Hydroxypyrrolidin-2-one

Similarity: 0.89

Related Parent Nucleus of
[ 34368-52-0 ]

Pyrrolidines

Chemical Structure| 77510-50-0

A155432 [77510-50-0]

(R)-3-Hydroxypyrrolidin-2-one

Similarity: 1.00

Chemical Structure| 15166-68-4

A158781 [15166-68-4]

3-Hydroxy-2-pyrrolidinone

Similarity: 1.00

Chemical Structure| 25747-41-5

A106534 [25747-41-5]

4-Hydroxy-2-pyrrolidone

Similarity: 0.89

Chemical Structure| 68108-18-9

A181193 [68108-18-9]

(S)-4-Hydroxypyrrolidine-2-one

Similarity: 0.89

Chemical Structure| 22677-21-0

A369559 [22677-21-0]

(R)-4-Hydroxypyrrolidin-2-one

Similarity: 0.89